|
|
|
Volumn 111, Issue 2 Suppl 1, 2011, Pages
|
|
Optimizing outcomes for GLP-1 agonists.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
DRUG DERIVATIVE;
EXENDIN 4;
GLIMEPIRIDE;
GLUCAGON LIKE PEPTIDE 1;
GLYCOSYLATED HEMOGLOBIN;
INCRETIN;
LIRAGLUTIDE;
METFORMIN;
PEPTIDE;
SULFONYLUREA DERIVATIVE;
VENOM;
ALGORITHM;
BODY WEIGHT;
CASE REPORT;
DRUG EFFECT;
DRUG POTENTIATION;
GLUCOSE BLOOD LEVEL;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
TREATMENT OUTCOME;
ALGORITHMS;
BLOOD GLUCOSE;
BODY WEIGHT;
DIABETES MELLITUS, TYPE 2;
GLUCAGON-LIKE PEPTIDE 1;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCRETINS;
MALE;
METFORMIN;
MIDDLE AGED;
PEPTIDES;
SULFONYLUREA COMPOUNDS;
TREATMENT OUTCOME;
VENOMS;
|
|
EID: 79958267473
PISSN: None
EISSN: 19451997
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (0)
|
